23andMe stocks plunge after company files for bankruptcy and CEO quits

Published



Shares of 23andme stocks fell more than 57% Monday after the San Francisco-based genetics company announced late Sunday it had filed for bankruptcy and its chief executive had resigned. 

CEO Anne Wojcicki, who will remain on the board, has failed multiple times to rescue the flagging business by trying to buy it back. 

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.